Cancer Forum

Tag: midstage

  • Alnylam lung drug fails mid-stage trial

    —

    by

    admin
    in

    Alnylam lung drug fails mid-stage trial (Reuters) – Alnylam Pharmaceuticals Inc&#39s experimental drug to treat a variety of respiratory infection in lung transplant patients missed the principal objective of a mid-stage trial. The drug, codenamed ALN-RSV01, is being developed to treat respiratory syncytial … Read a lot more on Reuters Relay for Life this weekend…